+49 30 327787-0
In the Life Sciences 2025 Global Practice Guide by Chambers and Partners, Dr. Constanze Püschel, Dr. Ulrich Grau and Dr. Tobias Volkwein provide an overview of current trends and developments in the German healthcare system. In total, the articles in the guide cover the legal systems of over 20 countries.
Our lawyers' contribution provides an analysis of current developments in the German life sciences sector. The partners provide an overview of the German healthcare system, the influence of statutory health insurance and how digital initiatives, such as the e-prescription and regulatory changes, such as the Digital Act (DigiG), continue to push forward digitalization in Germany.
The focus lies on the financial stability of the healthcare system, the improvement of the legal framework for conducting clinical trials through the MFG, the impact of legislative changes regarding the pricing of medicines and the implementation of the HTA regulation in January 2025.
Furthermore, the partners provide an outlook on the discussed revision of the EU pharmaceutical legislation package, which aims to reduce the regulatory requirements for medicinal products and further enhance innovation.
You can access the chapter here.
